Inhibition of fibroblast growth factors
- 1 February 1996
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 38 (1), 109-119
- https://doi.org/10.1007/bf01803789
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Why Monitor Angiogenic factors in Patients' Urine?JNCI Journal of the National Cancer Institute, 1994
- Heparin‐Binding Growth Factor Blockade with Pentosan PolysulfateAnnals of the New York Academy of Sciences, 1993
- Detectable Inhibition of Heparin-Binding Growth Factor Activity in Sera From Patients Treated With Pentosan PolysulfateJNCI Journal of the National Cancer Institute, 1993
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapyThe British Journal of Radiology, 1993
- Inhibition by Pentosan Polysulfate (PPS) of Heparin-Binding Growth Factors Released From Tumor Cells and Blockage by PPS of Tumor Growth in AnimalsJNCI Journal of the National Cancer Institute, 1992
- Sequestration and Release of Basic Fibroblast Growth FactoraAnnals of the New York Academy of Sciences, 1991
- Interleukin-4 is a potent mitogen for capillary endotheliumBiochemical and Biophysical Research Communications, 1991
- Bifunctional effects of transforming growth factor-β (TGF-β) on endothelial cell growth correlate with phenotypes of TGF-β binding sitesExperimental Cell Research, 1990
- THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINSAnnual Review of Biochemistry, 1989